893 / 1498
University of Chicago Experience
Patients and methods:
•
211 histologically confirmed stage III-IV DLBCL
patients who received R-CHOP from January 2000 to May 2012 at
University of Chicago
•
110 stage III-IV DLBCL pts in CR (86% by PET) after R-CHOP
•
14 (12.7%) received RT
Shi, IJROBP, 2013